Monopar Therapeutics (MNPR) Q1 2023 Earnings

11MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-0.22
-0.21
-0.2
-0.19

Details

Expected EPS
-0.22
Actual EPS
-0.19
Surprise EPS
0.03
Surprise Percent
+13.64%

Description

Monopar Therapeutics (MNPR) has reported earnings of -0.19 per share for Q1 2023.

0 Comments

Share your thoughts